These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 18050300)

  • 1. Safe use of infliximab for the treatment of fistulizing Crohn's disease during pregnancy within 3 months of conception.
    Angelucci E; Cocco A; Viscido A; Caprilli R
    Inflamm Bowel Dis; 2008 Mar; 14(3):435-6. PubMed ID: 18050300
    [No Abstract]   [Full Text] [Related]  

  • 2. [Term pregnancy in a patient with Crohn's disease under treatment with adalimumab].
    Sánchez Muñoz D; Hoyas Pablos E; Ramírez Martín Del Campo M; Núñez Hospital D; Guerrero Jiménez P
    Gastroenterol Hepatol; 2005; 28(7):435. PubMed ID: 16137481
    [No Abstract]   [Full Text] [Related]  

  • 3. Systemic amyloidosis with Crohn's disease treated with infliximab.
    Park YK; Han DS; Eun CS
    Inflamm Bowel Dis; 2008 Mar; 14(3):431-2. PubMed ID: 17932971
    [No Abstract]   [Full Text] [Related]  

  • 4. Hidradenitis suppurativa and Crohn's disease: response to treatment with infliximab.
    Martínez F; Nos P; Benlloch S; Ponce J
    Inflamm Bowel Dis; 2001 Nov; 7(4):323-6. PubMed ID: 11720323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term treatment of rectovaginal fistulas in Crohn's disease: response to infliximab in the ACCENT II Study.
    Sands BE; Blank MA; Patel K; van Deventer SJ;
    Clin Gastroenterol Hepatol; 2004 Oct; 2(10):912-20. PubMed ID: 15476155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid recovery of a rectovaginal fistula with infliximab in a patient with Crohn's disease.
    Hagiu C; Badea R; Serban A; Petrar S; Andreica V
    J Gastrointestin Liver Dis; 2010 Sep; 19(3):329-32. PubMed ID: 20922201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Indications and results of infliximab in Crohn's disease].
    Karoui S; Boubaker J; Filali A
    Tunis Med; 2004 Dec; 82(12):1057-63. PubMed ID: 15822505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infliximab therapy improves the bone metabolism in fistulizing Crohn's disease.
    Miheller P; Muzes G; Zagoni T; Toth M; Racz K; Tulassay Z
    Dig Dis; 2006; 24(1-2):201-6. PubMed ID: 16699279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An open-label study of thalidomide for maintenance therapy in responders to infliximab in chronically active and fistulizing refractory Crohn's disease.
    Sabate JM; Villarejo J; Lemann M; Bonnet J; Allez M; Modigliani R
    Aliment Pharmacol Ther; 2002 Jun; 16(6):1117-24. PubMed ID: 12030953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulators and "on demand" therapy with infliximab in Crohn's disease: clinical experience with 400 infusions.
    Kinney T; Rawlins M; Kozarek R; France R; Patterson D
    Am J Gastroenterol; 2003 Mar; 98(3):608-12. PubMed ID: 12650795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome of perianal fistulizing Crohn's disease treated with infliximab.
    Bouguen G; Siproudhis L; Gizard E; Wallenhorst T; Billioud V; Bretagne JF; Bigard MA; Peyrin-Biroulet L
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):975-81.e1-4. PubMed ID: 23376316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Remicade (infliximab) in the treatment of Crohn disease].
    Brazier F; Delcenserie R; Dupas JL
    Presse Med; 2000 Sep; 29(16):1463-4. PubMed ID: 11039091
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical and radiological responses after infliximab treatment for perianal fistulizing Crohn's disease.
    Rasul I; Wilson SR; MacRae H; Irwin S; Greenberg GR
    Am J Gastroenterol; 2004 Jan; 99(1):82-8. PubMed ID: 14687146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infliximab therapy in 30 patients with refractory pediatric crohn disease with and without fistulas in The Netherlands.
    de Ridder L; Escher JC; Bouquet J; Schweizer JJ; Rings EH; Tolboom JJ; Houwen RH; Norbruis OF; Derkx BH; Taminiau JA
    J Pediatr Gastroenterol Nutr; 2004 Jul; 39(1):46-52. PubMed ID: 15187780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged duration of response to infliximab in early pediatric Crohn's disease.
    Kugathasan S
    J Pediatr Gastroenterol Nutr; 2001 Sep; 33 Suppl 1():S40-3. PubMed ID: 11685975
    [No Abstract]   [Full Text] [Related]  

  • 16. Review article: efficacy of infliximab in Crohn's disease--induction and maintenance of remission.
    Rutgeerts PJ
    Aliment Pharmacol Ther; 1999 Sep; 13 Suppl 4():9-15; discussion 38. PubMed ID: 10597334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged duration of response to infliximab in early but not late pediatric Crohn's disease.
    Kugathasan S; Werlin SL; Martinez A; Rivera MT; Heikenen JB; Binion DG
    Am J Gastroenterol; 2000 Nov; 95(11):3189-94. PubMed ID: 11095340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infliximab: lack of efficacy on perforating complications in Crohn's disease.
    Miehsler W; Reinisch W; Kazemi-Shirazi L; Dejaco C; Novacek G; Ferenci P; Herbst F; Karner J; Téleky B; Schober E; Vogelsang H
    Inflamm Bowel Dis; 2004 Jan; 10(1):36-40. PubMed ID: 15058525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infliximab (Remicade), a new biological treatment for Crohn's disease.
    D'Haens GR
    Ital J Gastroenterol Hepatol; 1999; 31(6):519-20. PubMed ID: 10575573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of infliximab in the treatment of Crohn's disease in children and adolescents.
    Hyams JS
    J Pediatr Gastroenterol Nutr; 2001 Sep; 33 Suppl 1():S36-9. PubMed ID: 11685974
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.